It may be the tastiest health claim on the internet. You have seen it in headlines, heard it from friends, maybe even repeated it yourself with a square of 85% cocoa already in your mouth: dark chocolate is good for your heart. Some versions go further — that a daily dose is practically medicine, that cardiologists secretly approve, that you can offset dessert with heart health. In an age of viral wellness advice, chocolate might be the one vice the culture gave us permission to keep.

The claim is unusually persistent, and unusually old. Scientists have been arguing about cocoa and the heart for more than two decades, and in 2022 the largest and most rigorous test of the idea ever run finally reported its results. The findings made headlines around the world: a 27% reduction in deaths from cardiovascular disease. If you stopped reading there, the viral claim would look like an open-and-shut case.

But the rest of the story is where the honesty lives. The trial did not test chocolate. Its headline result was not the outcome it was designed to prove. The amount of flavanols used would require eating hundreds of calories of chocolate a day. And many of the bars on store shelves would give you a daily dose of lead and cadmium along the way. So: is dark chocolate actually good for your heart? The honest answer is mostly yes — with qualifications that matter more than the headlines.

*Illustration: the heart-health claim, examined like any other medical question. Image: Unsplash.*

The Viral Claim

In its strongest form, the claim circulating online goes like this: dark chocolate protects the heart — it lowers blood pressure, improves blood flow, cuts cholesterol, and reduces the risk of heart disease and stroke. Some posts frame it as settled science; others present it as a delicious secret the medical establishment wants you to miss. The logic feels intuitive. Dark chocolate tastes slightly bitter, and bitter plant foods are supposed to be the healthy ones. It is rich in antioxidants, and antioxidants are supposed to protect arteries. The claim has the shape of something true, which is precisely what makes it worth checking carefully.

The first thing to separate is the part that holds up from the part that gets exaggerated. Researchers do not credit chocolate itself with magic properties. They credit a family of plant compounds called flavanols — also called flavan-3-ols — found in cocoa beans, and also in green and black tea, apples, grapes, and berries. The theory is that these compounds help blood vessels produce nitric oxide, a molecule that relaxes and widens artery walls, improving circulation and easing blood pressure. That mechanism is plausible, and it has been tested in human beings, not just test tubes. But “chocolate contains compounds that benefit blood vessels” is a much narrower statement than “eat dark chocolate for a healthy heart” — and the gap between those two sentences is where the viral version does its mischief.

Where the Story Started: The Kuna of Panama

The chocolate-heart story has a genuine origin story, and it begins on a cluster of islands off the coast of Panama. In the early 2000s, researchers led by Norman Hollenberg at Harvard Medical School were studying the Kuna people, who live on the San Blas islands in the Caribbean. Among the island-dwelling Kuna, high blood pressure and other signs of cardiovascular disease were rare. The islanders were also known to drink large amounts of flavanol-rich cocoa — three to four cups per day.

The striking detail was what happened when Kuna people moved to the suburbs of Panama City on the mainland. Those migrants drank far less cocoa — only about four cups per week — and, as Hollenberg’s team found, they did not enjoy the same level of cardiovascular health. The implication was that something about the cocoa, rather than something about the Kuna’s genes, was protecting their hearts.

A follow-up investigation pushed the mechanism further. Hagen Schroeter and colleagues compared urine samples from island-dwelling and mainland Kuna and found that the islanders had more than twice the levels of urinary nitric oxide — the compound associated with healthy blood flow through the arteries. The team then ran a five-part investigation to pin down which cocoa compound was responsible, and the evidence pointed to epicatechin, one of cocoa’s key flavanols. As Schroeter put it, the work supplied “direct proof that epicatechin is, at least in part, responsible for the beneficial vascular effects that are observed after the consumption of certain flavanol-rich cocoas.”

Hollenberg summed up the implication: “These findings suggest that frequent intake of cocoa flavanols can have biological effects with important implications for long-term cardiovascular health.”

There is, however, a footnote that has followed this research from the beginning. The studies were financially supported by Mars, Incorporated — one of the world’s largest chocolate manufacturers, which also supplied the flavanol-rich cocoa used in the investigations. Industry funding does not automatically invalidate a study, but it is a conflict of interest worth naming, because the same company that sells chocolate has spent decades funding the science that makes chocolate look healthy. That funding pattern would repeat in the biggest trial of all.

The Compound That Does the Work

Before the trials, it helps to understand what scientists think flavanols actually do inside the body. Flavanols are a subgroup of flavonoids, the bitter-tasting compounds plants make to defend themselves. Cocoa’s most studied flavanol is epicatechin. When you consume flavanol-rich cocoa, the compounds are absorbed into the bloodstream, and laboratory and clinical work has linked them to increased production of nitric oxide in blood vessel walls. Nitric oxide signals the smooth muscle around arteries to relax, the vessels widen, and blood flows more easily. Lower resistance in the arteries means lower blood pressure and, over time, less strain on the heart.

This is also why cocoa’s flavanols get discussed in the same breath as tea, apples, and berries — they all contain flavan-3-ols. The Medscape review of the evidence put it plainly: these bioactive compounds “may lower blood pressure and improve endothelial function.” In short trials, flavanol-rich cocoa has been tied to better blood-vessel flexibility and small drops in blood pressure, and a review of flavanol-fortified cocoa products found vascular gains across doses from about 45 mg to more than 1,000 mg a day.

Europe even gave the mechanism a measure of regulatory blessing. In 2012, the European Food Safety Authority issued a positive scientific opinion, and the European Commission granted a health claim — initially for Barry Callebaut’s products — stating that “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow,” at a daily intake of 200 mg of cocoa flavanols. That claim can be attached to cocoa beverages or dark chocolate providing at least 200 mg a day. It is not an endorsement of candy bars as medicine, but it is an unusually concrete official statement in a field where most food claims never clear the evidence bar.

*Illustration: the beneficial compounds are not exclusive to chocolate — tea, apples, grapes, and berries contain flavanols too. Image: Unsplash.*

The Big Test: COSMOS

Everything before 2022 was, by the standards of medical evidence, preliminary. Small trials. Short durations. Biomarkers rather than real heart attacks and deaths. The Kuna observations were fascinating but observational — correlations, not proof. What the field needed was a large, long, randomized trial, and that is what the COcoa Supplement and Multivitamin Outcomes Study — COSMOS — was designed to be.

COSMOS was led by investigators at Brigham and Women’s Hospital and Harvard Medical School and enrolled 21,442 older U.S. adults — women 65 and older, men 60 and older — who were free of recent heart attacks, strokes, and recent cancer. The participants were randomly assigned to take either a daily cocoa extract capsule containing 500 mg of cocoa flavanols (including 80 mg of epicatechin) or a placebo, and they were followed for a median of 3.6 years. The capsules were supplied by Mars Edge, a segment of Mars, Incorporated. The cardiovascular results were published in the American Journal of Clinical Nutrition in 2022.

Here is what the trial found, and the distinction between its two main results is the single most important fact in this entire story.

The trial’s primary outcome — a composite of total cardiovascular events, including heart attacks, strokes, coronary revascularizations, cardiovascular death, carotid and peripheral artery surgery, and unstable angina — fell by 10% in the cocoa group. But that difference was not statistically significant: the hazard ratio was 0.90, with a confidence interval of 0.78 to 1.02. In plain language, the main result leaned in a helpful direction but could still have been chance. The trial, by its own prespecified standard, was negative.

A prespecified secondary endpoint told a more encouraging story. Deaths from cardiovascular disease fell by 27% — a hazard ratio of 0.73, with a confidence interval of 0.54 to 0.98. That number is real and statistically significant. It is also not the result the trial was built to prove, and secondary endpoints are treated with more caution than primary ones precisely because trials test many of them.

When the researchers restricted the analysis to participants who reliably took their capsules, the effects strengthened: total cardiovascular events fell by a significant 15%, and cardiovascular death by 39%. The trial found no significant effect on cancer, the other major outcome it was designed to test.

Study leader JoAnn Manson was careful in her framing, describing the findings as promising but preliminary and noting that any real health benefit would need confirming in a future trial before it could be recommended as guidance. That caution matters, because it is the opposite of how the results were absorbed by the wellness internet, where “27% fewer deaths” quickly became “chocolate saves lives.”

*Illustration: the 21,000-person COSMOS trial is the closest thing the field has to a decisive test. Image: Unsplash.*

Beyond COSMOS: Blood Pressure and the Heart

COSMOS is the headline trial, but it sits on top of a larger body of work, and the supporting evidence points mostly in the same direction.

A meta-analysis of 145 randomized controlled trials with more than 5,200 participants confirmed favorable effects of flavan-3-ols on blood pressure and endothelial function. The average daily intake in those trials was 586 mg of flavan-3-ols — roughly two to three cups of tea or one to two servings of dark chocolate — and it produced an average reduction of 2.8 mm Hg in systolic blood pressure and 2.0 mm Hg in diastolic blood pressure. In people with hypertension, the effect was stronger: reductions of 6 to 7 mm Hg in systolic pressure. Flow-mediated dilation, a measure of how well blood vessels relax, improved by an average of 1.7%, even in people with normal blood pressure. The compounds were generally well tolerated; adverse events were uncommon and typically mild, most often limited to gastrointestinal discomfort.

A separate line of evidence comes from Mendelian randomization — a genetic technique that uses natural genetic variation as a stand-in for a randomized experiment. A study of this type found that dark chocolate intake was significantly associated with a 27% reduction in the risk of essential hypertension, as well as a suggestive association with a 31% lower risk of venous thromboembolism. Notably, the study found no association between dark chocolate intake and ten other cardiovascular diseases. That selectivity is itself informative: it suggests the effect is real but narrow, not a general shield against all heart trouble.

Earlier observational work added color. A 2015 study published in the journal Heart found that people who ate 15 to 100 grams of chocolate a day — anything from candy bars to hot cocoa — had lower risks of heart disease and stroke than non-eaters, including an 11% lower risk of heart disease and a 25% lower risk of associated death. A study of atrial fibrillation by researcher Elizabeth Mostofsky found that people eating one serving of chocolate a week had a 17% lower rate of the arrhythmia than near-abstainers, and those eating two to six servings a week had a 20% lower rate — though the benefit tapered off at a serving or more per day. As Mostofsky cautioned, “Eating excessive amounts of chocolate is not recommended because many chocolate products are high in calories from sugar and fat and could lead to weight gain and other metabolic problems. But moderate intake of chocolate with high cocoa content may be a healthy choice.”

One more mechanistic detail is worth knowing. A study comparing high-flavanol dark chocolate (1,064 mg of flavanols per day for six weeks) against low-flavanol dark chocolate in men with pre-hypertension or mild hypertension found modest improvements in vascular function — and found that chocolate’s effect on platelet aggregation, a measure of clot risk, appeared to be driven not by flavanols but by theobromine, another cocoa compound. The point: cocoa is a cocktail of active substances, and “flavanols” is only part of the explanation.

The Fine Print: Dose, Calories, Processing, and Heavy Metals

This is the section the viral posts leave out. Every piece of it is necessary to an honest verdict.

First, the dose problem. COSMOS used a standardized 500 mg of flavanols per day in a capsule — and capsules are not chocolate. Ordinary dark chocolate is wildly variable in flavanol content, and matching the trial’s dose through chocolate alone would mean eating hundreds of extra calories daily. The European health claim’s threshold of 200 mg a day is easier to reach, but it too assumes a product that actually retains its flavanols.

Second, processing destroys flavanols. Traditional chocolate-making often alkalizes cocoa — so-called “Dutched” processing, which mellows the bitter taste — and that step strips out most of the flavanol content. A high cocoa percentage on the label does not guarantee high flavanols; percentage tells you about cocoa solids, not about how the beans were treated. Two bars at 85% can have very different flavanol levels.

Third, the calorie math. As cardiology professor Frank Ruschitzka of University Hospital Zurich has noted, while cocoa of at least 70% “reduces oxidative stress and improves vascular and platelet function,” roughly 100 grams of dark chocolate carries about 500 calories — a sum he says should be subtracted from the rest of the day’s food to avoid weight gain. The saturated fat in chocolate is real, and as one medical review put it, “the amount of saturated fats consumed easily can outweigh any potential benefits.” Any honest accounting of chocolate as a health food has to put the flavanol benefit on the same scale as several hundred calories of sugar and fat.

Fourth, the heavy metals. Consumer Reports scientists tested 28 popular dark chocolate bars in 2022 and found lead and cadmium in all of them. For 23 of the 28 bars, eating just one ounce a day would put an adult over California’s maximum allowable dose level for at least one of the metals; five bars exceeded the limits for both. A subsequent study in Frontiers in Nutrition, reviewing 72 dark chocolate products tested between 2014 and 2022, found average lead and cadmium levels that exceeded California’s strict thresholds, driven by heavily contaminated outliers. Cadmium is absorbed from the soil by the cacao plant; lead appears to settle on beans from dust during sun-drying after harvest. Lead contributes to hypertension in adults, and cadmium exposure has been linked to cardiovascular problems — the very outcomes chocolate is supposed to prevent. Harvard Health’s summary was blunt: choose safer brands or simply enjoy chocolate occasionally rather than frequently.

Fifth, and finally, the funding footnote from earlier deserves its place in any verdict. Mars supplied the capsules for COSMOS and funded the Kuna follow-up research. When the largest beneficiary of a health claim is also the largest funder of the science behind it, the responsible reader adjusts their confidence accordingly — not to zero, because the trial design was genuinely rigorous, but downward.

*Health claims about chocolate spread fast online — the trial data tells a more careful story. Image: Unsplash.*

What Cardiologists Actually Say

The professionals who treat hearts for a living land in a consistent place: cautious openness, not enthusiasm. Cardiologist Matthew Kahn told Stylist that dark varieties can have “a legitimate place in a heart-conscious diet, as long as portions stay sensible,” explaining: “High cocoa dark chocolate (70% or more) contains compounds called flavonoids, which can support blood vessel health and slightly lower blood pressure.” Fellow cardiologist Charlie Cox pointed to the evidence directly, calling cacao “one of the most polyphenol-rich foods on the planet” and noting that “the flavanols have real cardiovascular evidence behind them.”

The other half of the professional consensus is restraint. Dietitians who debunk heart-health myths for a living stress that the evidence applies only to high-flavanol dark chocolate — not milk chocolate, not white chocolate, and not Dutch-processed varieties. The broader message from heart-health professionals is that there are no superfoods. As one summary of dietitian guidance put it: fruits, vegetables, and whole grains have antioxidants too, without chocolate’s calorie load. If you like chocolate, enjoy it in moderation — as a treat, not a prescription.

Nobody credible prescribes chocolate the way they prescribe a statin or blood pressure medication, and nobody credible should. The supplements-and-trials review of COSMOS put it well: cocoa flavanols are “a reasonable adjunct for middle-aged and older adults with cardiovascular risk factors, not a replacement for a statin.”

How the Claim Gets Overstated

It is worth mapping exactly how a nuanced evidence base becomes an overblown viral claim, because the pattern repeats across wellness culture.

Step one is the capsule-to-candy-bar leap. COSMOS tested a standardized extract capsule, not a chocolate bar. The viral version quietly swaps the capsule for the candy and keeps the 27% figure.

Step two is the endpoint swap. The trial’s primary outcome — total cardiovascular events — missed statistical significance. The 27% reduction was in cardiovascular death, a secondary endpoint. Headlines routinely report the secondary result without mentioning that it was not the question the trial was designed to answer.

Step three is the disappearance of the caveats: the older-adult population, the calorie cost, the Dutch-processing problem, the heavy metals, the industry funding. What survives is a clean, delicious slogan: chocolate is good for your heart.

And step four is the implication of permission. “Chocolate is heart-healthy” gets heard as “eating more chocolate is healthy,” which is the opposite of what any of this evidence says. Every serious reading lands on small amounts of high-cocoa, minimally processed chocolate — an ounce a few times a week, in the words of cardiologist Stephen Sinatra — not on daily indulgence.

The Verdict

Mostly True.

The claim that dark chocolate benefits the heart rests on a real foundation. Cocoa flavanols have a credible mechanism — nitric oxide-mediated blood-vessel relaxation — supported by laboratory work, short-term human trials, and a plausible observational origin story in the cocoa-drinking Kuna. The largest randomized trial ever conducted, COSMOS, found a statistically significant 27% reduction in cardiovascular death among older adults taking cocoa flavanol extract over 3.6 years, and meta-analyses of shorter trials confirm small but real reductions in blood pressure, stronger in people with hypertension. Europe’s food-safety authority found the vascular evidence strong enough to grant a formal health claim. Cardiologists acknowledge the compounds have genuine cardiovascular evidence behind them.

The “mostly” carries a great deal of weight. The trial tested a 500 mg flavanol capsule, not chocolate bars, and its primary endpoint did not reach statistical significance. Ordinary chocolate is unreliable as a delivery vehicle: flavanol content varies wildly, Dutch processing destroys much of it, and matching research doses means consuming hundreds of calories of sugar and fat. Many popular dark chocolate bars also carry lead and cadmium contamination that argues against daily consumption. And the science has been substantially funded by the chocolate industry.

So the accurate version of the claim is this: cocoa flavanols appear to genuinely support blood-vessel function and may reduce cardiovascular risk, and a small amount of high-cocoa, minimally processed dark chocolate is a reasonable way for a heart-conscious person to enjoy them. What the evidence does not support is the viral version — that chocolate is a heart medicine, that more is better, or that a daily bar belongs in a treatment plan. As with so many things in nutrition, the truth is less exciting than the headline, and more useful.

The next time someone tells you chocolate is good for your heart, you can tell them the fuller story: the compounds are real, the trial is real, and the 27% number is real — but it came from a capsule, not a candy bar. The heart, it turns out, does not care what the wrapper says.